精华制药：2025年前三季度净利润约1.76亿元

Group 1 - The core viewpoint of the article highlights the financial performance of Jinghua Pharmaceutical for the third quarter of 2025, showing growth in revenue and net profit compared to the previous year [1] - The company's revenue for the first three quarters of 2025 is approximately 1.092 billion yuan, representing a year-on-year increase of 4.51% [1] - The net profit attributable to shareholders is around 176 million yuan, reflecting a year-on-year increase of 7.39% [1] - Basic earnings per share are reported at 0.2148 yuan, which is a 6.49% increase year-on-year [1] Group 2 - As of the report, Jinghua Pharmaceutical has a market capitalization of 6.2 billion yuan [2]